193 related articles for article (PubMed ID: 32850389)
1. Indolent T-Cell Lymphoproliferative Disease of the GI Tract: Insights for Better Diagnosis, Prognosis, and Appropriate Therapy.
Küçük C; Wei L; You H
Front Oncol; 2020; 10():1276. PubMed ID: 32850389
[TBL] [Abstract][Full Text] [Related]
2. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
Wang XG; Yin WH; Wang HY
Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
[TBL] [Abstract][Full Text] [Related]
3. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
[TBL] [Abstract][Full Text] [Related]
4. Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract.
Perry AM; Bailey NG; Bonnett M; Jaffe ES; Chan WC
Int J Surg Pathol; 2019 Feb; 27(1):102-107. PubMed ID: 29986618
[TBL] [Abstract][Full Text] [Related]
5. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
van Vliet C; Spagnolo DV
Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
[TBL] [Abstract][Full Text] [Related]
6. Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review.
Fan W; Niu L; He H; Yuan J; Yuan F; Shi X; Wang Y; Chen M; Huang M; Zhou F; Xu J; Chen Q
Virchows Arch; 2023 Apr; 482(4):729-743. PubMed ID: 36472661
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders.
Soderquist CR; Bhagat G
Semin Diagn Pathol; 2020 Jan; 37(1):11-23. PubMed ID: 31522873
[TBL] [Abstract][Full Text] [Related]
8. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
Wang X; Ng CS; Chen C; Yu G; Yin W
Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
[TBL] [Abstract][Full Text] [Related]
9. Primary Gastrointestinal T-Cell Lymphoma and Indolent Lymphoproliferative Disorders: Practical Diagnostic and Treatment Approaches.
Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830926
[TBL] [Abstract][Full Text] [Related]
10. CD8-positive indolent T-Cell lymphoproliferative disorder of the gastrointestinal tract: A case report and review of literature.
Weng CY; Ye C; Fan YH; Lv B; Zhang CL; Li M
World J Clin Cases; 2022 May; 10(15):4971-4984. PubMed ID: 35801019
[TBL] [Abstract][Full Text] [Related]
11. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.
Perry AM; Warnke RA; Hu Q; Gaulard P; Copie-Bergman C; Alkan S; Wang HY; Cheng JX; Bacon CM; Delabie J; Ranheim E; Kucuk C; Hu X; Weisenburger DD; Jaffe ES; Chan WC
Blood; 2013 Nov; 122(22):3599-606. PubMed ID: 24009234
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic approach to T- and NK-cell lymphoproliferative disorders in the gastrointestinal tract.
Susan SH; Ng SB; Wang S; Tan SY
Semin Diagn Pathol; 2021 Jul; 38(4):21-30. PubMed ID: 34016481
[TBL] [Abstract][Full Text] [Related]
13. Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a tricky diagnosis of a gastric case.
Zanelli M; Zizzo M; Sanguedolce F; Martino G; Soriano A; Ricci S; Castro Ruiz C; Annessi V; Ascani S
BMC Gastroenterol; 2020 Oct; 20(1):336. PubMed ID: 33054767
[TBL] [Abstract][Full Text] [Related]
14. Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract.
Soderquist CR; Patel N; Murty VV; Betman S; Aggarwal N; Young KH; Xerri L; Leeman-Neill R; Lewis SK; Green PH; Hsiao S; Mansukhani MM; Hsi ED; de Leval L; Alobeid B; Bhagat G
Haematologica; 2020 Jul; 105(7):1895-1906. PubMed ID: 31558678
[TBL] [Abstract][Full Text] [Related]
15. Feline low-grade intestinal T cell lymphoma: a unique natural model of human indolent T cell lymphoproliferative disorder of the gastrointestinal tract.
Freiche V; Cordonnier N; Paulin MV; Huet H; Turba ME; Macintyre E; Malamut G; Cerf-Bensussan N; Molina TJ; Hermine O; Bruneau J; Couronné L
Lab Invest; 2021 Jun; 101(6):794-804. PubMed ID: 33692440
[TBL] [Abstract][Full Text] [Related]
16. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.
Montes-Moreno S; King RL; Oschlies I; Ponzoni M; Goodlad JR; Dotlic S; Traverse-Glehen A; Ott G; Ferry JA; Calaminici M
Virchows Arch; 2020 May; 476(5):667-681. PubMed ID: 31773249
[TBL] [Abstract][Full Text] [Related]
17. Indolent T-Cell Lymphoproliferative Disorders of the Gastrointestinal Tract (iTLPD-GI): A Review.
Sanguedolce F; Zanelli M; Zizzo M; Luminari S; Martino G; Soriano A; Ricci L; Caprera C; Ascani S
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34205136
[TBL] [Abstract][Full Text] [Related]
18. Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma.
Zing NPC; Fischer T; Zain J; Federico M; Rosen ST
Oncology (Williston Park); 2018 Aug; 32(8):e83-e89. PubMed ID: 30153323
[TBL] [Abstract][Full Text] [Related]
19. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
Cheminant M; Bruneau J; Malamut G; Sibon D; Guegan N; van Gils T; Cording S; Trinquand A; Verkarre V; Lhermitte L; Brousse N; Jannot AS; Khater S; Frenzel L; Delarue R; Suarez F; Marçais A; Mulder CJ; Macintyre E; Asnafi V; Pouyet L; Bonnafous C; Lhospice F; Molina TJ; Meresse B; Cellier C; Cerf-Bensussan N; Hermine O;
Gut; 2019 Aug; 68(8):1396-1405. PubMed ID: 30448772
[TBL] [Abstract][Full Text] [Related]
20. Indolent T-Cell Lymphoproliferative Disease: A Rare Case of a Benign Lymphoma of the Gastrointestinal Tract With Extra-Gastrointestinal Involvement.
David R; Mishra K; Gilbert ER; Mirza KM; Hendler S
ACG Case Rep J; 2022 Oct; 9(10):e00879. PubMed ID: 36247380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]